Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New UV laser could make LASIK safer and more precise

NCT ID NCT07036835

Disease control Sponsor: Alcon Research Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 26, 2026 · Updated 4 times

Summary

This study tests a new ultraviolet femtosecond laser for creating corneal flaps during LASIK surgery to correct refractive errors. About 128 participants in Australia will receive LASIK using either the new UV laser or an existing infrared laser. The main goal is to check how safe and accurate the new laser is by measuring flap thickness and any side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
WaveLight Ultraviolet Femtosecond Laser (device)
What this could lead to
If successful, this could provide a safer, more precise way to create corneal flaps during LASIK, potentially improving vision correction outcomes.
What could go wrong
This is an early safety study with only 128 people, so results may not apply to everyone. Risks include flap complications or vision loss, though these are monitored closely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

128 people

The number who actually took part.

Started

Aug 2025

Finished

Aug 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion Criteria: * Eligible for LASIK treatment; * Myopia as specified in the protocol; * Uncorrected distance visual acuity of greater than or equal to 0.30 logMAR; * Best corrected distance visual acuity of less than or equal to 0.10 logMAR; * Presence of clear natural lens (non-cataractous eye); * Other protocol-defined inclusion criteria may apply. Key Exclusion Criteria: * An active implanted device for which laser use may be a contraindication; * Previous ocular surgery; * Ocular conditions that may affect subject safety or impact study outcomes; * Acute or chronic disease or illness that would increase the operative risk or confound the outcomes of the study; * Current use of medications with known ocular side effects and photosensitivity; * Other protocol-defined exclusion criteria may apply.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myopia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

myopia refractive error

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Refractive errors

Contacts and locations

Locations

  • Personaleyes

    Sydney, New South Wales, 2000, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.